Showing 531-540 of 2792 results for "".
Clarification of Call Coverage: Always a Duty of Neurologists
https://practicalneurology.com/columns/practice-management/PN0809_06-php/30897/Acupuncture for Headache Management: What is the Evidence? Where Do We Go from Here?
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0309_07-php/30938/Recent research of higher quality than that of the past suggests a possible role for acupuncture in headache care.New Diagnostic Tool Approved for Evaluation of Dementia Patients
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/new-diagnostic-tool-approved-for-evaluation-of-dementia-patients/30778/Amyvid, which indicates levels of beta-amyloid plaques in the brain, can help guide the diagnosis of dementia.Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.Hometown Highlights: Congenital Myasthenic Syndromes
https://practicalneurology.com/diseases-diagnoses/neuromuscular/hometown-highlights-congenital-myasthenic-syndromes/30130/With careful diagnosis, treatment can improve symptoms of congenital myasthenic syndromes.Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pathway-to-success-ms-drug-takes-nrf-2-pathway-for-treatment/30774/BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-in-the-preventive-treatment-of-chronic-migraine-and-other-headaches/30833/While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.Helping Patients Navigate Barriers To Diagnostic Testing For Neurological Disorders
https://practicalneurology.com/diseases-diagnoses/imaging-testing/helping-patients-navigate-barriers-to-diagnostic-testing-for-neurological-disorders/30580/Discoveries based on the human genome have yielded greater insights about the role of genetics in disease. New diagnostic tests can help clinicians accurately diagnose a disorder and get the patient on an effective treatment plan more quickly than ever before.